Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch article

A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors

Dana Inbar-Rozensal1 email, Asher Castiel2 email, Leonid Visochek1 email, David Castel1 email, Françoise Dantzer3 email, Shai Izraeli2 email and Malka Cohen-Armon1 email

The Neufeld Cardiac Research Institute and Dept. of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

Cancer Research Institute, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel

Laboratory of Molecular and Structural Biology, Ecole Superieure de Biotechnologie de Strasbourg, F-67400, Illkrich-Graffenstaden, France

author email corresponding author email

Breast Cancer Research 2009, 11:R78doi:10.1186/bcr2445

Published: 9 November 2009


See related editorial by Frizzell and Kraus, http://breast-cancer-research.com/content/11/6/111


Additional files

Additional file 1:

The following additional data are available with the online version of this article: A documented experiment, testing PJ-34 treatment in nude mice injected with MDA231 breast cancer cells (Additional data file 1).

Format: PDF Size: 1015KB Download file

This file can be viewed with: Adobe Acrobat Reader


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.